To our knowledge, this is the first case report on the successful treatment of hypercalcemia of malignancy caused by PTHrP and 1,25-dihydroxyvitamin D<sub>3</sub> cosecretion in a patient with lung cancer. Here, PTHLH is linked to hypercalcemia disease.